193 related articles for article (PubMed ID: 36181640)
1. Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma.
Fuller AM; DeVine A; Murazzi I; Mason NJ; Weber K; Eisinger-Mathason TSK
Cell Oncol (Dordr); 2022 Dec; 45(6):1277-1295. PubMed ID: 36181640
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
[TBL] [Abstract][Full Text] [Related]
3. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
Gray KS; Forrest JC; Speck SH
J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
Rajendran G; Shanmuganandam K; Bendre A; Muzumdar D; Goel A; Shiras A
J Neurooncol; 2011 Sep; 104(2):483-94. PubMed ID: 21229291
[TBL] [Abstract][Full Text] [Related]
5. An integrated epigenetic and genetic analysis of DNA methyltransferase genes (DNMTs) in tumor resistant and susceptible chicken lines.
Yu Y; Zhang H; Tian F; Zhang W; Fang H; Song J
PLoS One; 2008 Jul; 3(7):e2672. PubMed ID: 18648519
[TBL] [Abstract][Full Text] [Related]
6. DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma.
Camero S; Vitali G; Pontecorvi P; Ceccarelli S; Anastasiadou E; Cicchetti F; Flex E; Pomella S; Cassandri M; Rota R; Marampon F; Marchese C; Schiavetti A; Megiorni F
Cells; 2021 Oct; 10(11):. PubMed ID: 34831178
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the
Liu S; Liu L; Xu G; Cao Z; Wang Q; Li S; Peng N; Yin J; Yu H; Li M; Xia Z; Zhou L; Lin Y; Wang X; Li Q; Zhu C; Yang X; Wang J; She Y; Lu M; Zhu Y
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651365
[TBL] [Abstract][Full Text] [Related]
8. Methyltransferase DNMT3B in leukemia.
Zhang H; Ying H; Wang X
Leuk Lymphoma; 2020 Feb; 61(2):263-273. PubMed ID: 31547729
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and function of de novo DNA methylation in placental development reveals an essential role for DNMT3B.
Andrews S; Krueger C; Mellado-Lopez M; Hemberger M; Dean W; Perez-Garcia V; Hanna CW
Nat Commun; 2023 Jan; 14(1):371. PubMed ID: 36690623
[TBL] [Abstract][Full Text] [Related]
10. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
[TBL] [Abstract][Full Text] [Related]
11. A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding.
Gopalakrishnan S; Van Emburgh BO; Shan J; Su Z; Fields CR; Vieweg J; Hamazaki T; Schwartz PH; Terada N; Robertson KD
Mol Cancer Res; 2009 Oct; 7(10):1622-34. PubMed ID: 19825994
[TBL] [Abstract][Full Text] [Related]
12. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.
Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R
Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations of human DNA methyltransferase 3B with selective inhibitor nanaomycin A.
Caulfield T; Medina-Franco JL
J Struct Biol; 2011 Nov; 176(2):185-91. PubMed ID: 21839172
[TBL] [Abstract][Full Text] [Related]
14. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
15. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
[TBL] [Abstract][Full Text] [Related]
16. Tunable DNMT1 degradation reveals DNMT1/DNMT3B synergy in DNA methylation and genome organization.
Scelfo A; Barra V; Abdennur N; Spracklin G; Busato F; Salinas-Luypaert C; Bonaiti E; Velasco G; Bonhomme F; Chipont A; Tijhuis AE; Spierings DCJ; Guérin C; Arimondo P; Francastel C; Foijer F; Tost J; Mirny L; Fachinetti D
J Cell Biol; 2024 Apr; 223(4):. PubMed ID: 38376465
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells.
Rajabi H; Tagde A; Alam M; Bouillez A; Pitroda S; Suzuki Y; Kufe D
Oncogene; 2016 Dec; 35(50):6439-6445. PubMed ID: 27212035
[TBL] [Abstract][Full Text] [Related]
18. Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis.
Okuda K; Nakahara K; Ito A; Iijima Y; Nomura R; Kumar A; Fujikawa K; Adachi K; Shimada Y; Fujio S; Yamamoto R; Takasugi N; Onuma K; Osaki M; Okada F; Ukegawa T; Takeuchi Y; Yasui N; Yamashita A; Marusawa H; Matsushita Y; Katagiri T; Shibata T; Uchida K; Niu SY; Lang NB; Nakamura T; Zhang KYJ; Lipton SA; Uehara T
Nat Commun; 2023 Feb; 14(1):621. PubMed ID: 36739439
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferases 3A and 3B target specific sequences during mouse gastrulation.
Mukamel Z; Lifshitz A; Mittnenzweig M; Chomsky E; Schwartzman O; Ben-Kiki O; Zerbib M; Tanay A
Nat Struct Mol Biol; 2022 Dec; 29(12):1252-1265. PubMed ID: 36510023
[TBL] [Abstract][Full Text] [Related]
20. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine.
Oka M; Meacham AM; Hamazaki T; Rodić N; Chang LJ; Terada N
Oncogene; 2005 Apr; 24(19):3091-9. PubMed ID: 15735669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
